Related Experiment Video
Updated: Feb 12, 2026
11:06
Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
Published on: January 31, 2022
5.4K
Nonacetaminophen Drug-Induced Acute Liver Failure
Arul M Thomas1, James H Lewis2
1MedStar Georgetown Transplant Institute, MedStar Georgetown University Hospital, 3800 Reservoir Road NW, Washington, DC 20007, USA.
Clinics in Liver Disease
|April 2, 2018
Summary
Drug-induced acute liver failure is a serious condition, with non-acetaminophen causes accounting for 11% of cases. These non-acetaminophen drug injuries have a worse prognosis than acetaminophen-induced liver failure.
Area of Science:
- Hepatology
- Clinical Toxicology
- Drug Safety
Background:
- Acute liver failure (ALF) affects 2000-2500 US patients annually.
- Drug-induced liver injury (DILI) is the primary cause of ALF, comprising over 50% of cases.
- Non-acetaminophen DILI represents a significant subset, accounting for 11% of ALF cases.
Purpose of the Study:
- To highlight the clinical significance of non-acetaminophen drug-induced acute liver failure.
- To contrast the prognosis of non-acetaminophen DILI with acetaminophen-induced ALF.
- To emphasize the need for multidisciplinary management of acute liver failure.
Main Methods:
- Analysis of data from the US Acute Liver Failure Study Group registry.
- Review of diagnosed cases of acute liver failure.
- Comparative analysis of outcomes based on causative agents (acetaminophen vs. non-acetaminophen drugs).
Main Results:
- Non-acetaminophen drug injury constitutes 11% of all acute liver failure cases.
- Acute liver failure necessitates a multidisciplinary management approach.
- Non-acetaminophen-induced acute liver failure exhibits a more ominous prognosis compared to acetaminophen-induced cases.
Conclusions:
- Non-acetaminophen drug-induced acute liver failure carries a lower liver transplant-free survival rate.
- Early recognition and management are crucial for improving outcomes in acute liver failure.
- Further research into non-acetaminophen DILI is warranted to improve patient survival.
More Related Videos
16:19Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure
Published on: September 13, 2014
13.2K
09:44Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
11.1K
Related Concept Videos
01:21Acute Respiratory Failure-I
1.1K
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.1K
01:21Acute Respiratory Failure-II
1.2K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.2K
01:29Acute Respiratory Failure-V
515
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
515
01:30Acute Respiratory Failure-III
943
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
943
01:23Acute Respiratory Failure-IV
578
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
578
01:22Heart Failure Drugs: Diuretics
1.0K
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.0K